First Treatment for Breast Cancer with certain Inherited Gene Mutation
Journal: Scientific Journal of Genetics and Gene Therapy (Vol.4, No. 1)Publication Date: 2018-07-28
Authors : Sulaiman Naseer;
Page : 001-001
Keywords : ;
Abstract
The U.S. Food and Drug Administration approved use of Lynparza (olaparib tablets) treat certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer.
Other Latest Articles
Last modified: 2019-01-10 21:12:50